Cluster Headache Study
Cluster headache (CH) has been described as one of the most painful conditions a human can experience. Its nickname, suicide headache, accurately conveys the sentiment many cluster patients feel when in a cluster cycle. CH can be divided into to groups: those that cluster (that is, the headaches occur for weeks, are then gone for many months, then return. This is called episodic cluster), and those that no longer cluster (chronic cluster), but rather occur every day without interruption. Acute therapies include inhaled oxygen and sumatriptan injections, but there are no preventive treatments currently approved by the Food and Drug Administration (FDA).
At NEICR we’re committed to helping cluster headache patients. Over the years, we’ve been involved in more cluster studies then just about any other research organization. Some of these projects have gone on to become fully approved medications by the FDA.
NEICR is conducting a trial for patients who are currently struggling with Episodic Cluster Headaches. This trial has two 4-week periods with a 16-week observational period afterward. In the first 4-week period, patents could receive either placebo or active medication. This would switch for the second period, so anyone who received placebo the first time would definitely receive the active medication during this phase. This study is looking at a medication currently approved by the FDA for the treatment and prevention of migraine headaches. Click the button to view more information about this study on clinicaltrials.gov or use the form at the bottom of the page to have us contact you. Learn More
We would like to announce that we are offering a trial for patients with Chronic Cluster Headaches. The trial lasts for a full year and includes four infusions of medication. This medication is already approved by the FDA for the treatment and prevention of migraine headaches. This study is an open label study, so anyone meets the qualifying criteria and passes screening for the study would be guaranteed medication. There is no placebo arm for this study. Click the button to view more information about this study on clinicaltrials.gov or use the form at the bottom of the page to have us contact you. Learn More
If you or someone you know suffers from this devastating condition, please call us at 203-914-1903. Even if we don’t have an active study that’s a right fit for you, we’ll get your information and contact you as soon as one opens up.
Study procedures at NEICR come at no cost to you, and there may be compensation provided for time and travel. To enroll or learn more fill out the form below or call us at 203-914-1903.
Use the form below to let us know you are interested: